Samuele Cazzamalli

Samuele Cazzamalli

Company: Philochem

Job title: Head, Small Molecule Therapeutics


Pan-Tumoral Small Molecule-Drug Conjugates Targeting Fibroblasts Activation Protein in Solid Lesions 5:15 pm

OncoFAP is a clinically validated small organic ligand targeting FAP in solid tumors Discover how OncoFAP-drug conjugates selectively target tumors in vivo and release high amount of MMAE at the site of disease Explore how OncoFAP-drug conjugates potently induce anti-tumor response at doses below tumor saturation both in monotherapy and in combination with immunotherapyRead more

day: day 1- pm

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.